Listing Details

Fermenta Biotech Limited's existing 2,94,30,987 equity shares of face value ₹5 each were listed and admitted to dealings on the National Stock Exchange of India Limited (NSE) on August 4, 2026. The shares will trade under the symbol FERMENTA and ISIN INE225B01021. The company's equity shares will continue to remain listed on the BSE under Scrip Code 506414.

Event Commemoration

The listing milestone was commemorated through a ceremonial bell-ringing event held at the NSE's Exchange Plaza office in Mumbai's Bandra Kurla Complex. The event was attended by representatives from NSE, Fermenta's Board and senior leadership team, and other stakeholders.

Company Background

Fermenta Biotech Limited is one of the world's largest manufacturers of Vitamin D3 API and maintains a growing portfolio of premium-grade nutritional ingredients, green chemistry, APIs and customized food premixes. Founded in 1951 and listed on the BSE since 1977, the company celebrates its 75-year journey in 2026. The company serves customers in more than 60 countries with manufacturing facilities located at:

  • Kullu (Himachal Pradesh)
  • Dahej (Gujarat)
  • Tirupati (Andhra Pradesh)

The company is supported by an R&D Excellence Centre at Thane (near Mumbai) and serves over 400 customers across pharmaceuticals, dietary supplements, food & beverage, veterinary, and animal nutrition industries.

Strategic Rationale

The dual listing on both BSE and NSE is expected to:

  • Increase accessibility to shareholders and market participants across both major Indian stock exchanges
  • Support broader participation in the company's equity
  • Improve visibility and market recognition
  • Enable more efficient price discovery

Management Commentary

Prashant Nagre, Managing Director, stated: "Fermenta's listing on the NSE represents a significant milestone in a landmark year for the Company, as we commemorate 75 years of Fermenta and nearly five decades as a publicly listed enterprise, alongside important recognitions in food safety and workplace culture. It reflects a journey shaped by resilience and a path forward defined by innovation, scale and focus. We will continue to enhance our capabilities across nutrition, food fortification, green chemistry and specialised solutions."

He further added: "The NSE listing further strengthens our capital-market presence and reaffirms our commitment to transparency, responsible governance and consistent engagement with shareholders. We extend our sincere appreciation to our promoters, Board, shareholders, employees, customers, partners and all other stakeholders for their continued confidence in Fermenta."

Safe Harbour Statement

The document includes standard forward-looking statements disclaimer noting that statements about future status, events, or circumstances are subject to numerous risks and uncertainties including market conditions, regulatory changes, competitive dynamics, and other business risks.